HMS Holdings scoops up patient engagement startup Eliza for $170 million
HMS Holdings announced that it has acquired patient engagement specialist Eliza Corporation for $170 million in cash.
HMS owns a number of subsidiaries that offer software tools for payers. Eliza sells SaaS services to employers, providers, health plans, hospitals, pharmacies and clinics to help them engage customers for different use cases, such as medication adherence.
Eliza uses what it calls “smart profiling” to figure out which is the best way to reach each customer, at which time of day and through which channel, be it text message, phone calls, email, snail mail, their website or via existing mobile apps.
The cloud-based platform uses proprietary predictive analytics, behavioral science and data-driven outreach methodologies that have led to Eliza accruing more than 50 domestic and international patents and patent applications (which will all go to HMS under the acquisition).
"Payers are seeking reliable insights and actionable information to manage risk and improve the quality of care delivered. The addition of Eliza will position HMS to impact both revenue and costs for our health plan customers, while continuing to supply needed tools to more effectively manage the care of their members across all markets,” HMS CEO and Chairman Bill Lucia said in a statement. “This acquisition will represent an additional building block in our strategic expansion into the fields of care and population analytics and risk management, and will present both potential short and longer term growth avenues for HMS. We will also be able to utilize certain Eliza operational assets and analytics to strengthen the delivery of our core products.”